In a large retrospective study, radical prostatectomy was significantly associated with a survival advantage among men with high-risk prostate cancer compared with external beam radiation therapy.
The risks for metastasis, biochemical recurrence, and overall mortality are unaffected, according to investigators.
Compared with before the pandemic, men undergoing radical prostatectomy during the pandemic were more likely to have extraprostatic disease, according to investigators.
Neoadjuvant androgen deprivation therapy prior to prostate cancer surgery is feasible, investigators noted.
Biopsy Gleason patterns 4+5, 5+4, and 5+5 should be given separate consideration in pretreatment risk stratification, according to investigators.
The technical challenges and potential complications of extended PLND warrant careful consideration, according to investigators.
Study findings corroborate previous research linking higher income with increased healthcare utilization.
Primary focal and radiation therapy for prostate cancer are associated with different rates of perioperative complications and long-term urinary continence recovery.
Despite how common prostate cancer is in American men, misconceptions about its symptoms, detection, treatment, and management persist.
A single-institution study found no significant increase in the risk for complications or readmissions between patients who underwent robotic urologic surgery before and during the COVID-19 pandemic.
